TxO Austin Midtown — Austin, Texas

TxO Austin Midtown is a clinical research site located in Austin, Texas, United States 78705.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

TxO Austin Midtown has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TxO Austin Midtown?

TxO Austin Midtown has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TxO Austin Midtown conducted?

TxO Austin Midtown has 1 clinical trials on record, with 1 currently active. Their work covers Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

Is TxO Austin Midtown accredited by Crixeo Health?

TxO Austin Midtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TxO Austin Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.